on Wednesday said it was discontinuing its heart surgery robot business as it posted a 30% drop in second-quarter operating profit on shrinking demand for COVID-19 tests.
The "use of Corindus robots for cardiology operations did not fulfill our expectations," Chief Financial Officer Jochen Schmitz said on a press call. Schmitz added it will take several years before robots for neurological operations are ready for the market.
Colombia Últimas Noticias, Colombia Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Siemens Healthineers reports lower Q2 profit, discontinues heart surgery robots businessU.S.-German medical device maker Siemens Healthineers on Wednesday said it is giving up part of billion-dollar acquisition Corindus' business as it reported a 30% drop in quarterly operating profit on lower contributions from COVID tests.
Leer más »